Comparison of allergenic extracts from different origins: the value of the FDA’s bioequivalent allergy unit (BAU)
Introduction: Allergy immunotherapy (AIT) is the only disease-modifying intervention for the treatment of allergic diseases. The clinical effectiveness of AIT is clearly dose-dependent, so it is important that clinicians can assess and compare the potency of the various products available. However,...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
30 May 2016
|
| In: |
Expert review of clinical immunology
Year: 2016, Jahrgang: 12, Heft: 7, Pages: 733-739 |
| ISSN: | 1744-8409 |
| DOI: | 10.1080/1744666X.2016.1187561 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1080/1744666X.2016.1187561 Verlag, Volltext: https://doi.org/10.1080/1744666X.2016.1187561 
|
| Verfasserangaben: | Giovanni Passalacqua, Joaquín Sastre, Oliver Pfaar, Ulrich Wahn, Pascal Demoly |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1587631679 | ||
| 003 | DE-627 | ||
| 005 | 20230427034237.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190213s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/1744666X.2016.1187561 |2 doi | |
| 035 | |a (DE-627)1587631679 | ||
| 035 | |a (DE-576)517631679 | ||
| 035 | |a (DE-599)BSZ517631679 | ||
| 035 | |a (OCoLC)1341037929 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Passalacqua, Giovanni |e VerfasserIn |0 (DE-588)1177953250 |0 (DE-627)1049073061 |0 (DE-576)517631830 |4 aut | |
| 245 | 1 | 0 | |a Comparison of allergenic extracts from different origins |b the value of the FDA’s bioequivalent allergy unit (BAU) |c Giovanni Passalacqua, Joaquín Sastre, Oliver Pfaar, Ulrich Wahn, Pascal Demoly |
| 264 | 1 | |c 30 May 2016 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 13.02.2019 | ||
| 520 | |a Introduction: Allergy immunotherapy (AIT) is the only disease-modifying intervention for the treatment of allergic diseases. The clinical effectiveness of AIT is clearly dose-dependent, so it is important that clinicians can assess and compare the potency of the various products available. However, this is not possible in practice, because manufacturers use different methods to determine potency. Therefore, a clear need exists for adoption of a ‘gold-standard’ measure of allergenicity. The bioequivalent allergy unit (BAU) is thus far the only allergen unit approved by a regulatory agency (the US Food and Drug Administration), with European regulatory authorities yet to adopt a common unit.Areas covered: Using PubMed, we performed a review of the literature on measures of allergen extract potency, use of the BAU, and BAU assessment for grass pollen tablets.Expert commentary: There is an obvious benefit to allergists and patients for having a single, comparable unit across products, and we strongly support the adoption of a single, ‘gold-standard’ unit of measurement for all products. Use of the BAU allows a clear comparison of the potency of allergen products from different manufacturers, and enables better understanding of the potential reasons for any differences in administration and dosing protocols between these products. | ||
| 650 | 4 | |a Allergy immunotherapy | |
| 650 | 4 | |a bioequivalent allergy unit | |
| 650 | 4 | |a grass pollen allergy | |
| 650 | 4 | |a index of reactivity | |
| 650 | 4 | |a standardized quality tablet unit | |
| 700 | 1 | |a Pfaar, Oliver |d 1972- |e VerfasserIn |0 (DE-588)12385900X |0 (DE-627)706454049 |0 (DE-576)293913099 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert review of clinical immunology |d Abingdon, Oxon : Taylor & Francis, 2005 |g 12(2016), 7, Seite 733-739 |h Online-Ressource |w (DE-627)490222625 |w (DE-600)2191838-7 |w (DE-576)39810025X |x 1744-8409 |7 nnas |a Comparison of allergenic extracts from different origins the value of the FDA’s bioequivalent allergy unit (BAU) |
| 773 | 1 | 8 | |g volume:12 |g year:2016 |g number:7 |g pages:733-739 |g extent:7 |a Comparison of allergenic extracts from different origins the value of the FDA’s bioequivalent allergy unit (BAU) |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/1744666X.2016.1187561 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1080/1744666X.2016.1187561 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190213 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 12385900X |a Pfaar, Oliver |m 12385900X:Pfaar, Oliver |d 60000 |d 62100 |e 60000PP12385900X |e 62100PP12385900X |k 0/60000/ |k 1/60000/62100/ |p 3 | ||
| 999 | |a KXP-PPN1587631679 |e 3055866045 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"recId":"1587631679","note":["Gesehen am 13.02.2019"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"given":"Giovanni","family":"Passalacqua","role":"aut","display":"Passalacqua, Giovanni","roleDisplay":"VerfasserIn"},{"family":"Pfaar","given":"Oliver","roleDisplay":"VerfasserIn","display":"Pfaar, Oliver","role":"aut"}],"title":[{"title_sort":"Comparison of allergenic extracts from different origins","subtitle":"the value of the FDA’s bioequivalent allergy unit (BAU)","title":"Comparison of allergenic extracts from different origins"}],"relHost":[{"title":[{"title_sort":"Expert review of clinical immunology","title":"Expert review of clinical immunology"}],"recId":"490222625","language":["eng"],"disp":"Comparison of allergenic extracts from different origins the value of the FDA’s bioequivalent allergy unit (BAU)Expert review of clinical immunology","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 01.09.15"],"part":{"extent":"7","volume":"12","text":"12(2016), 7, Seite 733-739","issue":"7","pages":"733-739","year":"2016"},"pubHistory":["1.2005 -"],"id":{"issn":["1744-8409"],"eki":["490222625"],"zdb":["2191838-7"]},"origin":[{"dateIssuedDisp":"2005-","publisher":"Taylor & Francis ; Informa Healthcare","dateIssuedKey":"2005","publisherPlace":"Abingdon, Oxon ; London"}],"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"7 S."}],"name":{"displayForm":["Giovanni Passalacqua, Joaquín Sastre, Oliver Pfaar, Ulrich Wahn, Pascal Demoly"]},"id":{"doi":["10.1080/1744666X.2016.1187561"],"eki":["1587631679"]},"origin":[{"dateIssuedDisp":"30 May 2016","dateIssuedKey":"2016"}]} | ||
| SRT | |a PASSALACQUCOMPARISON3020 | ||